In this paper, the study of new 7-chloro-3-hydroxy-1
H-quinazoline-2,4-dione derivatives, designed as AMPAand kainate (KA) receptor antagonists, is reported. Some derivatives bear different carboxy-containing alkylchains on the 3-hydroxy group, while various heterocyclic rings or amide moieties are present at the 6-positionof other compounds. Binding data at Gly/NMDA, AMPA, and high-affinity KA receptors showed that thepresence of the free 3-hydroxy group is of paramount importance for a good affinity at all three investigatedreceptors, while introduction of some 6-heterocyclic moieties yielded AMPA-selective antagonists. Themost significant result was the finding of the 6-(2-carboxybenzoylamino)-3-hydroxy-1
H-quinazolin-2,4-dione
12, which possesses good affinity for high-affinity and low-affinity KA receptors (
Ki = 0.62
![](/images/entities/mgr.gif)
M and1.6
![](/images/entities/mgr.gif)
M, respectively), as well as good selectivity. To rationalize the trend of affinities of the reportedderivatives, an intensive molecular modeling study was carried out by docking compounds to models of theGly/NMDA, AMPA, and KA receptors.